316 related articles for article (PubMed ID: 19088019)
1. Pharmacogenetics in breast cancer therapy.
Tan SH; Lee SC; Goh BC; Wong J
Clin Cancer Res; 2008 Dec; 14(24):8027-41. PubMed ID: 19088019
[TBL] [Abstract][Full Text] [Related]
2. Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment.
Ramón y Cajal T; Altés A; Paré L; del Rio E; Alonso C; Barnadas A; Baiget M
Breast Cancer Res Treat; 2010 Jan; 119(1):33-8. PubMed ID: 19189210
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.
Gaston C; Kolesar J
Clin Adv Hematol Oncol; 2008 Nov; 6(11):825-33. PubMed ID: 19194367
[TBL] [Abstract][Full Text] [Related]
4. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.
Bernard S; Neville KA; Nguyen AT; Flockhart DA
Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.
Briest S; Stearns V
Clin Adv Hematol Oncol; 2009 Mar; 7(3):185-92. PubMed ID: 19398943
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of anti-estrogen treatment of breast cancer.
Del Re M; Michelucci A; Simi P; Danesi R
Cancer Treat Rev; 2012 Aug; 38(5):442-50. PubMed ID: 21917382
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
9. Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.
Kiyotani K; Mushiroda T; Zembutsu H; Nakamura Y
J Hum Genet; 2013 Jun; 58(6):327-33. PubMed ID: 23657426
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies.
Anglicheau D; Legendre C; Thervet E
Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118
[TBL] [Abstract][Full Text] [Related]
11. The ethics of CYP2D6 testing for patients considering tamoxifen.
Hartman AR; Helft P
Breast Cancer Res; 2007; 9(2):103. PubMed ID: 17433116
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD; Wang D; Sadee W
Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of chemotherapy efficacy in breast cancer.
González-Neira A
Pharmacogenomics; 2012 Apr; 13(6):677-90. PubMed ID: 22515610
[TBL] [Abstract][Full Text] [Related]
14. Germline genetic variation, cancer outcome, and pharmacogenetics.
Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Marsh S; Liu G
Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
Jabir RS; Naidu R; Annuar MA; Ho GF; Munisamy M; Stanslas J
Pharmacogenomics; 2012 Dec; 13(16):1979-88. PubMed ID: 23215890
[TBL] [Abstract][Full Text] [Related]
17. Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?
Brauch H; Jordan VC
Eur J Cancer; 2009 Sep; 45(13):2274-83. PubMed ID: 19592233
[TBL] [Abstract][Full Text] [Related]
18. [Genomic based approach to individualized cancer therapy].
Isomura M; Miki Y
Nihon Rinsho; 2010 Jun; 68(6):1117-20. PubMed ID: 20535965
[TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
Lee W; Lockhart AC; Kim RB; Rothenberg ML
Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
